Insider Transactions in Q3 2022 at Inhibrx, Inc. (INBX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2022
|
Brendan P. Eckelman Chief Scientific Officer |
BUY
Bona fide gift
|
Indirect |
160,000
+33.33%
|
-
|
|
Sep 13
2022
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Bona fide gift
|
Indirect |
160,000
-6.57%
|
-
|
|
Sep 06
2022
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.81%
|
$600,000
$15.26 P/Share
|
|
Aug 24
2022
|
Jon Faiz Kayyem Director |
SELL
Bona fide gift
|
Indirect |
11,900
-0.36%
|
-
|
|
Aug 05
2022
|
Jon Faiz Kayyem Director |
SELL
Bona fide gift
|
Indirect |
3,400
-0.1%
|
-
|
|
Aug 03
2022
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
15,500
-0.62%
|
$279,000
$18.47 P/Share
|
|
Aug 02
2022
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
24,500
-0.97%
|
$416,500
$17.7 P/Share
|
|
Aug 02
2022
|
Jon Faiz Kayyem Director |
BUY
Bona fide gift
|
Indirect |
50,000
+50.0%
|
-
|
|
Aug 02
2022
|
Jon Faiz Kayyem Director |
SELL
Bona fide gift
|
Indirect |
118,500
-3.49%
|
-
|
|
Jul 07
2022
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.57%
|
$680,000
$17.17 P/Share
|